Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug 12:12:681290.
doi: 10.3389/fendo.2021.681290. eCollection 2021.

Adipocyte-Endothelium Crosstalk in Obesity

Affiliations
Review

Adipocyte-Endothelium Crosstalk in Obesity

Rugivan Sabaratnam et al. Front Endocrinol (Lausanne). .

Abstract

Obesity is characterized by pathological adipose tissue (AT) expansion. While healthy AT expansion enhances systemic insulin sensitivity, unhealthy AT expansion through increased adipocyte size is associated with insulin resistance, fibrosis, hypoxia, and reduced adipose-derived adiponectin secretion. The mechanisms causing the unhealthy AT expansion are not fully elucidated; yet, dysregulated crosstalk between cells within the AT is an important contributor. Evidence from animal and human studies suggests a crucial role of the crosstalk between vascular endothelium (the innermost cell type in blood vessels) and adipocytes for metabolic homeostasis. Arterial endothelial cells are directly involved in maintaining normal organ functions through local blood flow regulation. The endothelial-dependent regulation of blood flow in AT is hampered in obesity, which negatively affects the adipocyte. Moreover, endothelial cells secrete extracellular vesicles (EVs) that target adipocytes in vivo. The endothelial EVs secretion is hampered in obesity and may be affected by the adipocyte-derived adipokine adiponectin. Adiponectin targets the vascular endothelium, eliciting organ-protective functions through binding to T-cadherin. The reduced obesity-induced adiponectin binding of T-cadherin reduces endothelial EV secretion. This affects endothelial health and cell-cell communication between AT cells and distant organs, influencing systemic energy homeostasis. This review focuses on the current understanding of endothelial and adipocyte crosstalk. We will discuss how obesity changes the AT environment and how these changes contribute to obesity-associated metabolic disease in humans. Particularly, we will describe and discuss the EV-dependent communication and regulation between adipocytes, adiponectin, and the endothelial cells regulating systemic energy homeostasis in health and metabolic disease in humans.

Keywords: adipose tissue; endocrine; endothelial cells; extracellular vesicles; hypoxia; nitric oxide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Adipocyte and endothelial crosstalk in adipose tissue contribute to regulation of whole-body glucose and lipid metabolism: In this working hypothesis, endothelial cells regulate blood flow adequately to adipocytes, which secrete adiponectin that communicate locally with endothelial cells and with distant organs such as muscle, liver, and heart. Adiponectin stimulates EV secretion from endothelial cells, ensuring their health e.g. through cellular waste management, and stimulates muscle, liver, and heart metabolism, improving systemic metabolism. EVs from adipocytes and endothelial cells may also target other cell types. Other adipocyte-derived factors, and overall endothelial health also contributes to regulation of whole-body glucose and lipid metabolism. Figure created with BioRender.com.

Similar articles

Cited by

References

    1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, et al. . Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss. Arterioscler Thromb Vasc Biol (2006) 26(5):968–76. 10.1161/01.ATV.0000216787.85457.f3 - DOI - PubMed
    1. Frayn KN. Adipose Tissue as a Buffer for Daily Lipid Flux. Diabetologia (2002) 45(9):1201–10. 10.1007/s00125-002-0873-y - DOI - PubMed
    1. Straub LG, Scherer PE. Metabolic Messengers: Adiponectin. Nat Metab (2019) 1(3):334–9. 10.1038/s42255-019-0041-z - DOI - PMC - PubMed
    1. Sun K, Tordjman J, Clement K, Scherer PE. Fibrosis and Adipose Tissue Dysfunction. Cell Metab (2013) 18(4):470–7. 10.1016/j.cmet.2013.06.016 - DOI - PMC - PubMed
    1. Jernas M, Palming J, Sjoholm K, Jennische E, Svensson PA, Gabrielsson BG, et al. . Separation of Human Adipocytes by Size: Hypertrophic Fat Cells Display Distinct Gene Expression. FASEB J (2006) 20(9):1540–2. 10.1096/fj.05-5678fje - DOI - PubMed

Publication types